Embelin is a benzoquinone compound, present mainly in Embelia species. Embelin is also reported in Lysimachia punctate, Ardisia humilis, Rapanea umbellate, Cannarus richiei, Myrsine Africana and Myrsine capitellata. Embelin has demonstrated wide range of pharmacological activities including; antidepressant, anticancer, antifertility, antidiabetic, antioxidant and analgesic. Embelin shown other activities also such as antihyperlipidemic, antifungal, antihyperhomocysteinemic, anthelminthic, anticonvulsant, antibacterial, hepatoprotective, wound healing and anxiolytic activity. Recent studies, have thrown light on anti-arthritis and antiulcer activities of the benzoquinone. The present review, discusses pharmacological investigations on embelin, with potential for drug-development.